Literature DB >> 21060018

Mitochondrial transfer RNA(Phe) mutation associated with a progressive neurodegenerative disorder characterized by psychiatric disturbance, dementia, and akinesia-rigidity.

Tim M Young1, Emma L Blakely, Helen Swalwell, Janet E Carter, Luke D Kartsounis, Dominic G O'Donovan, Douglass M Turnbull, Robert W Taylor, Rajith N de Silva.   

Abstract

BACKGROUND: Mitochondrial diseases are characterized by wide phenotypic and genetic variability, but presentations in adults with akinetic rigidity and hyperkinetic movement disorders are rare.
OBJECTIVES: To describe clinically a subject with progressive neurodegeneration characterized by psychosis, dementia, and akinesia-rigidity, and to associate this phenotype with a novel mitochondrial transfer RNA(Phe) (tRNA(Phe)) (MTTF) mutation. DESIGN, SETTING, AND PATIENT: Case description and detailed laboratory investigations of a 57-year-old woman at a university teaching hospital and a specialist mitochondrial diagnostic laboratory.
RESULTS: Histopathological findings indicated that an underlying mitochondrial abnormality was responsible for the subject's progressive neurological disorder, with mitochondrial genome sequencing revealing a novel m.586G>A MTTF mutation.
CONCLUSIONS: The clinical phenotypes associated with mitochondrial disorders may include akinesia-rigidity and psychosis. Our findings further broaden the spectrum of neurological disease associated with mitochondrial tRNA(Phe) mutations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21060018     DOI: 10.1001/archneurol.2010.283

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

1.  Mitochondrial disease--an important cause of end-stage renal failure.

Authors:  Shamima Rahman; Andrew M Hall
Journal:  Pediatr Nephrol       Date:  2012-12-12       Impact factor: 3.714

2.  Mitochondrial tRNA(Phe) mutation as a cause of end-stage renal disease in childhood.

Authors:  Kristin E D'Aco; Megan Manno; Colleen Clarke; Jaya Ganesh; Kevin E C Meyers; Neal Sondheimer
Journal:  Pediatr Nephrol       Date:  2012-11-08       Impact factor: 3.714

3.  Mitochondrion-toxic drugs given to patients with mitochondrial psychoses.

Authors:  Josef Finsterer
Journal:  Behav Brain Funct       Date:  2012-08-29       Impact factor: 3.759

Review 4.  The Role of the Transcription Factor Foxo3 in Hearing Maintenance: Informed Speculation on a New Player in the Cochlea.

Authors:  Patricia M White
Journal:  Biomed Res Int       Date:  2016-10-13       Impact factor: 3.411

5.  Mitochondrial myopathy plus due to the variant m.586G > A in MT-TF.

Authors:  Giulia Barcia; Zahra Assouline; Alessandra Pennisi; Julie Steffann; Nathalie Boddaert; Cyril Gitiaux; Agnès Rötig; Jean-Paul Bonnefont; Arnold Munnich
Journal:  Mol Genet Metab Rep       Date:  2019-10-23

6.  The Detection and Partial Localisation of Heteroplasmic Mutations in the Mitochondrial Genome of Patients with Diabetic Retinopathy.

Authors:  Afshan N Malik; Hannah S Rosa; Eliane S de Menezes; Priyanka Tamang; Zaidi Hamid; Anita Naik; Chandani Kiran Parsade; Sobha Sivaprasad
Journal:  Int J Mol Sci       Date:  2019-12-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.